SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001140361-22-029967
Filing Date
2022-08-17
Accepted
2022-08-17 09:01:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 POS AM brhc10040741_posam.htm POS AM 24201
  Complete submission text file 0001140361-22-029967.txt   25384
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Filer) CIK: 0001595893 (see all company filings)

IRS No.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-238300 | Film No.: 221172208
SIC: 2834 Pharmaceutical Preparations